Form D · Biotechnology
Starton Therapeutics Inc.
Paramus, NJ · CIK 0001743192
Offering snapshot reported Oct 22, 2024 · SEC filing
- Reported sold
- $2.13M Offering amount: $2.13M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 10, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 22, 2024 | Initial | $2,126,035 | No comparison | 16 | SEC filing |
| Oct 13, 2023 | Initial | $970,930 | No comparison | 8 | SEC filing |
| Apr 13, 2023 | Initial | $1,443,520 | No comparison | 7 | SEC filing |
| Jan 25, 2023 | Initial | $1,023,417 | No comparison | 11 | SEC filing |
| Feb 16, 2022 | Initial | $1,145,350 | No comparison | 9 | SEC filing |
| Nov 22, 2021 | Initial | $1,145,375 | No comparison | 39 | SEC filing |
| May 26, 2021 | Initial | $77,597 | No comparison | 5 | SEC filing |
| Jan 13, 2020 | Initial | $2,038,703 | No comparison | 25 | SEC filing |
| Jul 2, 2018 | Initial | $766,677 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-527514
Source: Form D, filed Oct 22, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kenneth Anderson | Director |
| Eric Baum | Director |
| Asher Chanan Khan | Director |
| Keith Darragh | Executive |
| Moses Dodo | Director |
| Mohamad Hussein | Director |
| Scott Kahn | Executive |
| Nitin Kaushal | Director |
| Nintin Kaushal | Director |
| Pedro Lichtinger | Director, Executive |
| Pedro Lichtinger Waisman | Director, Executive |
| Jamie Oliver | Executive |
| Litsa Perperidis | Promoter |
| Fotios Plakogiannis | Director |
| Roman Rogol | Director |
| Cidnee Vaykovich | Executive |
| Pedro Waisman | Director, Executive |
| Roy Waldon | Director |
| Roy Waldron | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
215 College Road, Suite #300
Paramus, NJ, 07652
Paramus, NJ, 07652